Literature DB >> 8745855

H pylori infection.

P S Phull, M R Jacyna.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8745855      PMCID： PMC1239514     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  7 in total

1.  Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.

Authors:  N Chiba; B V Rao; J W Rademaker; R H Hunt
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

2.  One-week low-dose triple therapy: new standards for Helicobacter pylori treatment.

Authors:  A Goddard; R Logan
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-01       Impact factor: 2.566

Review 3.  The role of acid inhibition in the treatment of Helicobacter pylori infection.

Authors:  A T Axon
Journal:  Scand J Gastroenterol Suppl       Date:  1994

4.  Eradication of Helicobacter pylori with clarithromycin and omeprazole.

Authors:  R P Logan; P A Gummett; H D Schaufelberger; R R Greaves; G M Mendelson; M M Walker; P H Thomas; J H Baron; J J Misiewicz
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

5.  Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

Authors:  G D Bell; K Powell; S M Burridge; A Pallecaros; P H Jones; P W Gant; G Harrison; J E Trowell
Journal:  Aliment Pharmacol Ther       Date:  1992-08       Impact factor: 8.171

6.  Factors influencing the eradication of Helicobacter pylori with triple therapy.

Authors:  D Y Graham; G M Lew; H M Malaty; D G Evans; D J Evans; P D Klein; L C Alpert; R M Genta
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

7.  The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease--a community-based study.

Authors:  P S Phull; S D Ryder; D Halliday; A B Price; A J Levi; M R Jacyna
Journal:  Postgrad Med J       Date:  1995-07       Impact factor: 2.401
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.